Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Clinical trial NCT01466595 · COMPLETED
Trial details
- NCT number
- NCT01466595
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.